RIQUENT
Dead / Cancelled — Cancelled — Section 8 (as of 03 Jul 2010)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78102996
- Registration number
- 2787557
- Mark type
- Word mark
- Filed
- 16 Jan 2002
- Published for opposition
- 10 Sept 2002
- Registered
- 25 Nov 2003
- Attorney of record
- Mark I. Peroff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases, namely, systemic lupus erythematosus, RH hemolytic disease of the newborn, antiphospholipid antibody syndrome, Grave's disease, myasthenia gravis, Hashimoto's thyroiditis, pemphigus, autoimmune hemolytic anemia, autoimmune thrombocytopenia purpura, antibody mediated infertility, Sjogre's syndrome, mixed connective tissue disease, glomerulonephritis and Goodpasture's syndrome
Owner
- La Jolla Pharmaceutical Company, San Diego, CA, US
- La Jolla Pharmaceutical Company, San Diego, CA, US
- La Jolla Pharmaceutical Company, San Diego, CA, US
Prosecution history
- 03 Jul 2010 — CANCELLED SEC. 8 (6-YR)
- 25 Nov 2003 — REGISTERED-PRINCIPAL REGISTER
- 29 Sept 2003 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Sept 2003 — ASSIGNED TO EXAMINER
- 17 Sept 2003 — CASE FILE IN TICRS
- 12 Aug 2003 — STATEMENT OF USE PROCESSING COMPLETE
- 13 May 2003 — USE AMENDMENT FILED
- 13 May 2003 — TEAS STATEMENT OF USE RECEIVED
- 04 Feb 2003 — SOU EXTENSION 1 GRANTED
- 04 Feb 2003 — SOU EXTENSION 1 FILED
- 04 Feb 2003 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2002 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 10 Sept 2002 — PUBLISHED FOR OPPOSITION
- 21 Aug 2002 — NOTICE OF PUBLICATION
- 12 Jun 2002 — APPROVED FOR PUB - PRINCIPAL REGISTER